Hypothyroidism due to medicaments and other exogenous substances
- E03.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Short description: Hypothyroidism due to meds and oth exogenous substances
- The 2025 edition of ICD-10-CM E03.2 became effective on October 1, 2024.
- This is the American ICD-10-CM version of E03.2 – other international versions of ICD-10 E03.2 may differ.
Use Additional
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Code First
- poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)
The following code(s) above E03.2 contain annotation back-references
that may be applicable to E03.2:
Approximate Synonyms
- Drug induced hypothyroidism
- Drug induced hypothyroidism, amiodarone
- Hypothyroidism due to amiodarone
- Hypothyroidism due to drug
- Hypothyroidism due to drug or other exogenous substance
- Hypothyroidism, iatrogenic
- Iatrogenic hypothyroidism
ICD-10-CM E03.2 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Convert E03.2 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Diagnosis Index entries containing back-references to E03.2:
- Hypothyroidism (acquired) E03.9
- due to
- exogenous substance NEC E03.2
- medicament NEC E03.2
- P-aminosalicylic acid E03.2 (PAS)
- phenylbutazone E03.2
- resorcinol E03.2
- sulfonamide E03.2
- thiourea group drugs E03.2
- iatrogenic NEC E03.2
- due to